qosina.com Listed by cactus Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

People who work with or supply medical-device components may have personal or business information caught up in a claimed ransomware incident involving qosina.com. Public reporting does not yet confirm how many individuals are affected or exactly which records left the company’s systems, so the practical risk remains uncertain but real for anyone whose details sit in supplier, customer, or internal files of this kind.

On 27 February 2024 the ransomware group known as cactus listed qosina.com on its leak site, asserting that internal files had been taken. That listing is a claim, not an independently verified confirmation of the full scope. For ordinary people connected to the firm—employees, partners, or contacts—the immediate concern is whether their data could later appear in criminal markets or be used for fraud.

What happened

According to the public listing dated 27 February 2024, cactus claimed to have exfiltrated internal files from qosina.com during a ransomware attack. The number of people affected is unknown. No further technical details—such as the initial access method, the precise date of intrusion, the volume of data, or whether encryption was also deployed—have been disclosed in the available record. The group’s leak-site entry presented the organisation as a medical-device manufacturer and included a brief company description, revenue figure, address and contact details, along with purported download links that are not reproduced here. Beyond the claim of internal-file exfiltration, the concrete contents of any stolen material remain unconfirmed.

The group behind it: cactus

Cactus is a ransomware operation that became publicly visible in 2023. Like many contemporary groups, it typically follows a double-extortion model: data are copied out of the victim network before systems are encrypted, after which the operators threaten to publish the material if a ransom is not paid. Victims are often listed on a dedicated leak site once negotiations stall or fail. The group has targeted organisations across multiple sectors, using common initial-access techniques such as compromised credentials or unpatched remote-access services, though the specific vector used against any single victim is rarely confirmed by independent sources. In this case the only public assertion is the leak-site listing itself; no additional statements by cactus about qosina.com appear in the available facts.

qosina.com and its sector

Qosina is described in the listing as a global supplier of more than 5,000 OEM single-use components used in the medical and biopharmaceutical industries. Public company information places it in Ronkonkoma, New York, with reported revenue of approximately $37.9 million. Organisations of this type sit in the medical-device supply chain: they design, mould and distribute plastic and other components that end up in finished devices, kits and manufacturing processes. Because they interact with device makers, contract manufacturers and regulatory documentation, they routinely hold commercial contracts, technical drawings, quality records, employee data and supplier or customer contact lists. A breach at such a firm can therefore affect not only its own workforce but also the broader ecosystem of companies that rely on its parts and documentation.

The information in question

The only data type named in the public record is “internal files” said to have been exfiltrated. No inventory of those files—whether they include employee records, customer lists, design files, financial documents or other categories—has been released. Organisations in the medical-component sector typically maintain personnel files, purchase orders, engineering specifications, quality-management records and correspondence with regulated customers. Until an independent confirmation or a fuller disclosure appears, it is not possible to state which of these categories, if any, were among the material cactus claims to hold. The exact contents therefore remain unconfirmed.

What's at stake

For individuals whose information may have been present, the concrete risks include identity fraud, targeted phishing that references real business relationships, and the long-term circulation of personal or contact data on criminal forums. For the organisation itself, the stakes include disruption of supply-chain relationships, potential regulatory scrutiny under data-protection or medical-device quality rules, and the cost of forensic investigation and remediation. Because the scale of the claimed exfiltration is unknown, the number of people who need to take protective steps cannot yet be quantified. The absence of confirmed victim counts does not eliminate the possibility that sensitive commercial or personal material has left the network.

What to do if you're exposed

If you have reason to believe your details were held by qosina.com—through employment, a business relationship or prior contact—practical first steps are straightforward and do not require waiting for further official confirmation.

• Monitor bank and credit-card statements for unfamiliar charges and place a fraud alert with the major credit bureaus if you are in a jurisdiction that offers that service.
• Change passwords on any accounts that reused credentials associated with the company, and enable multi-factor authentication wherever it is available.
• Treat unsolicited emails or calls that reference medical-device supply chains or Qosina with heightened caution; verify any request through a known, independent channel.
• Keep records of any suspicious activity so you can report it promptly to local authorities or your bank.
• Run a free exposure scan of your email address against known breach data sets to see whether your information has already appeared in other incidents; this does not confirm involvement in the present claim but can surface earlier exposures that warrant attention.

Public detail on this incident remains limited. Further verified information may emerge from company statements or independent analysis; until then, measured vigilance is the most useful response.

AICompiled with AI assistance from public sources and published under our editorial standards.